Determinants of tobacco use transitions in smoker nursing students in Catalonia: A prospective longitudinal study.

longitudinal study nursing students tobacco use tobacco use cessation transition

Journal

Tobacco induced diseases
ISSN: 1617-9625
Titre abrégé: Tob Induc Dis
Pays: Greece
ID NLM: 101201591

Informations de publication

Date de publication:
2024
Historique:
received: 17 03 2024
revised: 27 05 2024
accepted: 30 05 2024
medline: 9 7 2024
pubmed: 9 7 2024
entrez: 9 7 2024
Statut: epublish

Résumé

The use of emerging tobacco and nicotine products affects tobacco use behaviors among college students. Thus, we aimed to examine transitions in tobacco use patterns and identify their predictors among smokers in a cohort of nursing students in Catalonia (Spain). We conducted a prospective longitudinal study of Catalan nursing students between 2015-2016 and 2018-2019. We examined transitions in tobacco use patterns between baseline and follow-up among smokers from: 1) daily to non-daily smoking, 2) non-daily to daily smoking, 3) cigarette-only use to poly-tobacco use, 4) poly-tobacco use to cigarette-only use, 5) between products, 6) reducing consumption by ≥5 cigarettes per day (CPD); and 7) quitting smoking. We applied a Generalized Linear Model with a log link (Poisson regression) and robust variance to identify predictors of reducing cigarette consumption by ≥5 CPD and quitting smoking, obtaining both crude and adjusted (APR) prevalence ratios and their 95% confidence intervals (CIs). Among daily smokers at baseline, 12.1% transitioned to non-daily smoking at follow-up, while 36.2% of non-daily smokers shifted to daily smoking. Among cigarette-only users, 14.2% transitioned to poly-tobacco use, while 48.4% of poly-tobacco users switched to exclusive cigarette use. Among all smokers (daily and non-daily smokers), 60.8% reduced their cigarette consumption by ≥5 CPD and 28.3% quit smoking. Being a non-daily smoker (APR=0.33; 95% CI 0.19-0.55) and having lower nicotine dependence (APR=0.78; 95% CI 0.64-0.96) were inversely associated with reducing cigarette consumption, while being a non-daily smoker (APR=1.19; 95% CI: 1.08-1.31) was directly associated with quitting smoking. Nursing students who smoked experienced diverse transitions in tobacco use patterns over time. Evidence-based tobacco use preventive and cessation interventions are needed to tackle tobacco use among future nurses.

Identifiants

pubmed: 38978612
doi: 10.18332/tid/189484
pii: TID-22-126
pmc: PMC11229088
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

© 2024 Laroussy K. et al.

Déclaration de conflit d'intérêts

The authors have each completed and submitted an ICMJE form for Disclosure of Potential Conflicts of Interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. All authors report that since the initial planning of the work this research was funded by the Consell de Col·legis d’Infermeres i Infermeres de Catalunya (Grant CCIC 2016) and the Directorate of Research and Universities, Government of Catalonia (Grant 2021SGR00906). E. Fernández, C. Martínez and M. Fu report that in the past 36 months they received funding for the scientific activity developed by the Consolidated Research Group on Epidemiology, Prevention and Tobacco Control of IDIBELL from the Ministry of Research and Universities, Government of Catalonia (2021SGR00906). They have also received Institutional support to IDIBELL from the CERCA Programme, Generalitat de Catalunya. A. Peruga reports that in the past 36 months he has received Grants or contracts from the National Health Fund (Grant 21FIS031-PI20/00972) and the National Plan on Drugs (Grant MSP21006). He also reports serving as Secretary of the Tobacco-Free Aragonese Society.

Auteurs

Kenza Laroussy (K)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
School of Nursing, University of Barcelona, Barcelona, Spain.

Esteve Fernández (E)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Yolanda Castellano (Y)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Marcela Fu (M)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
School of Nursing, University of Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Antoni Baena (A)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
Department of e-Health, School of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain.

Ariadna Feliu (A)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Armando Peruga (A)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Center for Epidemiology and Health Policy, Faculty of Medicine, Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.

Mercè Margalef (M)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.

Olena Tigova (O)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Jordi Galimany (J)

School of Nursing, University of Barcelona, Barcelona, Spain.

Montserrat Puig (M)

School of Nursing, University of Barcelona, Barcelona, Spain.

Carmen Moreno (C)

School of Nursing, University of Barcelona, Barcelona, Spain.

Albert Bueno (A)

Nursing care management, Equip d'Atenció Primària de Roses, Institut Català de Salut, Girona, Spain.

Antonio López (A)

Nursing care management, Equip d'Atenció Primària - Valls Urbà, Institut Català de Salut, Tarragona, Spain.

Judith Roca (J)

Department of Nursing and Physiotherapy, School of Nursing and Physiotherapy, University of Lleida, Lleida, Spain.

Judith Saura (J)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.

Cristina Martínez (C)

WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia - ICO, Barcelona, Spain.
Tobacco Control Research Group, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Barcelona, Spain.
School of Nursing, University of Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, United States.

Classifications MeSH